NFKB1 and COVID-19: Several commonly used broad‐spectrum anti‐inflammatory or antiviral drugs are reused in COVID‐19, such as dexamethasone, HCQ, macrolide antibiotics, NSAIDs (e.g., acetylsalicylic acid and aspirin), remdesivir, NAC, and proteasome inhibitors (VL‐01, bortezomib, carfilzomib, and lxazomib) are associated with NF‐κB cascade inhibition (reviewed in Refs.